Neurocrine Biosciences, Inc.’s NBIX share price has dipped by 18.53%, which has investors questioning if this is right time ...

The Trump Administration's 10% tariff on all Chinese imports took effect on Feb. 4. Many unknowns remain, but Americans will ...

Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Gide’s Warsaw team advises Farmaceutici Procemsa on acquiring Laboratoria Natury, expanding in the Polish food supplement ...

The Federal Government has committed N1.2 billion in domestic resources to improve maternal and child health under the Child Nutrition ...

It's not the only blood pressure medication recall to happen in recent months, but the FDA's concern appears to follow a common theme.

JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company currently valued at $34.1 million, has announced a partnership with Catalent (NYSE:CTLT) Pharma ...

New Delhi: Pharmaceutical major Dr Reddy's has got approval from the Subject Expert Committee (SEC) functional under the ...

After struggling to get a diagnosis throughout her teen years, one Brit found salvation in the celebrity’s advice ...